PubMed Health⌕ Search

PubMed · 2913541

[Malignant arrhythmia].

Abstract

About 5 percent of the arrhythmias are serious, life threatening, malignant arrhythmias (MA). The MA is regularly associated with organic heart diseases (coronary heart disease, cardiomyopathy, valvular heart diseases), but a MA can develop without cardiac disorders e.g. in long QT syndrome or WPW syndrome. The most frequent type of the MA is the ventricular tachycardia (VT), mostly the sustained VT, not rarely degenerating to ventricular fibrillation (VF). The primary VF represents a rarer form of MA. The usual type of MA is the tachycardiac form, but there exists a MA with dominating bradycardia (bradycardia syncope, tachycardia associated with long lasting bradycardia). In the diagnosis of MA new investigatory methods (signal averaged electrography with high amplification, Holter monitoring, programmed electrical stimulation) play an important role. In the therapy of the MA the first step is the treatment of the cardiac disease involved in the pathogenesis of the MA. At present only about the 40% of the MA can be effectively treated with antiarrhythmic drugs. The pacemaker therapy is very efficacious in the bradycardiac type of MA. Cardiodefibrillator pacemaker can be used for the treatment of grave VT or VF. Electrical transvenous catheter ablation, heart surgical intervention can also be applied in the treatment of special MA. The prognosis of VA was very serious a decade ago, now with application of newer therapeutical procedure the prognosis of MA is permanently improving.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Solti. 1989-01-22. [Malignant arrhythmia].. https://pubmed.health/record/pubmed%3A2913541/malignant-arrhythmia

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related citations

Safety of nerve conduction studies in patients with implanted cardiac devices.

Patients with implanted cardiac devices and their physicians may defer important electrodiagnostic testing because of anxiety about potential negative effects on the device. To determine the safety of routine nerve conduction studies (NCS) in this population, 10 patients with permanent dual-chamber pacemakers of various types and five patients with implanted cardiac defibrillators (ICD) underwent nerve stimulation at sites commonly used during NCS. The implanted cardiac device was interrogated before and after the study and there was continuous monitoring of the surface electrocardiogram (ECG) and atrial and ventricular electrograms. Electrical impulses generated during routine NCS were never detected by the sensing amplifier and did not affect the programmed settings of the implanted cardiac device. We conclude that routine NCS is safe in patients with implanted cardiac pacemakers with bipolar sensing configurations and defibrillators.

Arrhythmias, Cardiac↗

[Pulmonary diseases and heart function].

The most severe cardiac sequel to lung disease is the load on the right ventricle due to pulmonary hypertension with the development of a cor pulmonale. This is characterized by hypertrophy and/or dilatation of the right ventricle because of a primary impairment of lung function and/or lung structure. The most important pathomechanisms for the development of pulmonary hypertension are vessel obliteration, mechanical lesions, primary vascular or extra-vascular inflammation and hypoxic vasoconstriction. Chronic obstructive pulmonary disease (COPD) is one of the most important reasons for chronic cor pulmonale. A further very common reason is obstructive sleep apnea syndrome, especially if combined with a COPD. In this case, the prevalence of cor pulmonale can reach 80%. The development of a chronic cor pulmonale is the most striking negative prognostic factor for these patients. Only 30% of COPD patients with cor pulmonale survive longer than 5 years, and only early detection of the disturbances to respiration which might potentially lead to cor pulmonale and their subsequent therapy are able to improve the patient's prognosis. Furthermore, pulmonary diseases may also have an impact on the left heart side in terms of an impairment of left heart function or by inducing severe arrhythmias . Thus, lung diseases may have both a significant impact on right and left heart performance.

Arrhythmias, Cardiac↗